TITLE

Extreme Obesity: A New Medical Crisis in the United States

AUTHOR(S)
Hensrud, Donald D.; Klein, Samuel
PUB. DATE
October 2006
SOURCE
Mayo Clinic Proceedings;Oct2006 Supplement, Vol. 81 Issue 10, pS5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The prevalence of obesity has markedly increased in the past few decades, and this disorder is responsible for more health care expenditures than any other medical condition. The greater the body mass index (BMI) (calculated as weight in kilograms divided by the square of height in meters), the greater the risk of comorbidities, including diabetes mellitus, hypertension, obstructive sleep apnea, many cancers, dyslipidemia, cardiovascular disease, and overall mortality. Class III (extreme) obesity, defined as a BMI of 40 kg/m² or greater, has also increased such that it now affects almost 1 in 20 Americans. The prevalence of extreme obesity is greater among women than among men and greater among blacks than among non-Hispanic whites or Hispanics. The effect of extreme obesity on mortality is greater among young than among older adults, greater among men than among women, and greater among whites than among blacks. The current permissive environment that promotes increased dietary energy intake and decreased energy expenditure through reduced daily physical activity coupled with genetic susceptibility Is an important pathogenic factor. The number of bariatric surgical procedures performed annually is relatively small but increasing.
ACCESSION #
23254799

 

Related Articles

  • Early gain in body mass with continuous positive airway pressure therapy for obstructive sleep apnea. Bourey, R. E.; Bourey, J. R.; Habbal, N.; Balaa, A. // Somnologie;Sep2010, Vol. 14 Issue 3, p207 

    Study objectives: Many clinicians believe that continuous positive airway pressure (CPAP) therapy of obstructive sleep apnea (OSA) is associated with a decrease in body mass, but to date, studies generally suggest long-term stability in body mass after 1 year. We have seen body mass increase...

  • Obesity and the Risk of Parkinson’s Disease. Chen, Honglei; Zhang, Shumin M.; Schwarzschild, Michael A.; Hernàn, Miguel A.; Willett, Walter C.; Ascherio, Alberto // American Journal of Epidemiology;Mar2004, Vol. 159 Issue 6, p547 

    Dopamine is involved in the regulation of food intake, and obese persons have decreased dopamine D2 receptor availability in the striatum. Furthermore, midlife triceps skinfold thickness has been found to be positively associated with the risk of Parkinson’s disease (PD) among...

  • Obesity linked to sleep apnea in drivers. Kvidera, Max // Commercial Carrier Journal;May2009, Vol. 166 Issue 5, p34 

    This article reports on a study which found that obesity-driven testing identifies commercial truck drivers with a high likelihood of obstructive sleep apnea (OSA). The study suggests that requiting OSA screenings could reduce the risk of truck crashes resulting from driver fatigue and...

  • Prevalence of Sleep Apnea in Morbidly Obese Patients Who Presented for Weight Loss Surgery Evaluation: More Evidence for Routine Screening for Obstructive Sleep Apnea before Weight Loss Surgery. Lopez, Peter P.; Stefan, Bianca; Schulman, Carl I.; Byers, Patricia M. // American Surgeon;Sep2008, Vol. 74 Issue 9, p834 

    The incidence of obstructive sleep apnea has been underestimated in morbidly obese patients who present for evaluation for weight loss surgery. This retrospective study shows that the incidence of obstructive sleep apnea in this patient population is greater than 70 per cent and increases in...

  • Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a dose-response meta-analysis of prospective cohort studies. Liu, Xue-ming; Liu, Yu-jian; Zhan, Jian; He, Qi-qiang // European Journal of Epidemiology;Jan2015, Vol. 30 Issue 1, p35 

    Overweight and obese individuals with type 2 diabetes are recommended to lose weight, but the associations between excess body weight and all-cause and cardiovascular mortality in patients with type 2 diabetes remain controversial. Therefore, we performed a dose-response meta-analysis to...

  • Surgical vs Conventional Therapy for Weight Loss Treatment of Obstructive Sleep Apnea. Dixon, John B.; Schachter, Linda M.; O'Brien, Paul E.; Jones, Kay; Grima, Mariee; Lambert, Gavin; Brown, Wendy; Bailey, Michael; Naughton, Matthew T. // JAMA: Journal of the American Medical Association;9/19/2012, Vol. 308 Issue 11, p1142 

    The article presents information about a research conducted for determining the surgically induced weight loss effectiveness than with conventional weight loss therapy in the management of obstructive sleep apnea (OSA). The research employed a randomized controlled clinical trial of 60 obese...

  • CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT LEADS TO WEIGHT GAIN IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME. Niculescu, D.; Kohler, W.; Coculescu, M. // Acta Endocrinologica (1841-0987);Oct-Dec2008, Vol. 4 Issue 4, p383 

    Obesity is an important risk factor for obstructive sleep apnea syndrome (OSAS). One would expect that effective treatment by continuous positive airway pressure (CPAP) would lead to weight loss due to decreased daytime sleepiness and improved physical activity. However, many papers suggest that...

  • Adhesion molecule increases in sleep apnea: beneficial effect of positive airway pressure and moderation by obesity. Pak, V M; Keenan, B T; Jackson, N; Grandner, M A; Maislin, G; Teff, K; Schwab, R J; Arnardottir, E S; Júlíusson, S; Benediktsdottir, B; Gislason, T; Pack, A I // International Journal of Obesity;Mar2015, Vol. 39 Issue 3, p472 

    Background:Elevated levels of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) may contribute to cardiovascular disease and are associated with obstructive sleep apnea (OSA) and obesity. The relationship between OSA and obesity in determining ICAM-1 and...

  • A novel biopsy method to increase yield of subcutaneous abdominal adipose tissue. Alderete, T L; Sattler, F R; Sheng, X; Tucci, J; Mittelman, S D; Grant, E G; Goran, M I // International Journal of Obesity;Jan2015, Vol. 39 Issue 1, p183 

    Collection of abdominal subcutaneous adipose tissue (SAT) for research testing is traditionally performed using punch biopsy or needle aspiration techniques, yielding small amounts of very superficial SAT (100-500 mg). Although liposuction techniques can be used to obtain large amounts of SAT,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics